A current insight into the drug–drug molecular adducts of an anti-cancer drug vandetanib with various NSAIDs

This study explores the molecular adducts of vandetanib, an anti-cancer medication, with several NSAIDs, using a well-known crystal engineering technique to improve physicochemical properties.

Authors

Institutions

Publication Details

Journal
CrystEngComm
Published
2025-01-01
DOI
https://doi.org/10.1039/d5ce00070j
Citations
2
Primary Topic
Chemical Reactions and Isotopes
Type
article
Field-Weighted Citation Impact
1.58
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A current insight into the drug–drug molecular adducts of an anti-cancer drug vandetanib with various NSAIDs

Dhilli Rao Gorja, Lopamudra Giri, Rambabu Dandela, K.G. Abishek et al.
2 citations
CrystEngComm
Chemical Reactions and Isotopes
1.58
article

A current insight into the drug–drug molecular adducts of an anti-cancer drug vandetanib with various NSAIDs

Dhilli Rao Gorja, Lopamudra Giri, Rambabu Dandela, K.G. Abishek, Gowtham Kenguva, Veera Venkat Shivaji Rama Rao Edupuganti
article en
2 citations

Abstract

This study explores the molecular adducts of vandetanib, an anti-cancer medication, with several NSAIDs, using a well-known crystal engineering technique to improve physicochemical properties.

CrystEngCommVol. 27(19)
University of Hyderabad (IN), Institute of Life Sciences (IN), Odisha University of Technology and Research, Indian Institute of Technology Hyderabad (IN)
Openalex Percentile: Top 18%
Chemical Reactions and Isotopes
1.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A current insight into the drug–drug molecular adducts of an anti-cancer drug vandetanib with various NSAIDs — Dhilli Rao Gorja, Lopamudra Giri, et al. · CrystEngComm (2025) | TGRS Research Map | TGRS